Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: how many shares in treasury

23,560,248 shares for $13,124,078 @ ~ $0.557 per share



Does it make sense for PTSC to give Crossflo 7.5 million in stock about 30 million shares... using treasury shares that we purchased at an average cost of 0.557. Total investment of 13 million in cash for a 7.5 million dollar deal?

Not to mention that we would still be 7-9 million shares short in the treasury stock to complete the deal.....



We would be giving up 10% of our shares structure to faciliate this deal...



Seems like we should just pay cash instead of stock.....use the T.Stock when our pps is back at those levels...



i dont know.. maybe im just off on the moon... i can see where Crossflo shareholders would want shares of PTSC...even though they would wait 1 year for the return



Granted we also dont know the financials of Crossflo..so maybe its totally justifiable...

Share
New Message
Please login to post a reply